Overview
This video demonstrates the protocol for developing pancreatic cancer stem cell spheroids in vitro. The assay can serve as a screening tool to identify compounds that potentially target cancer stem cells.
Protocol
1.Sphere Forming Assay and Analysis
- Sphere Formation Assay and Metformin Treatment
- Take the required number of cells and add the appropriate volume of CSCs medium to prepare a cell concentration of 2,000 cells/ml. Do not keep the cell suspension on ice for no longer than 1h and mixed well prior to plating.
- Add 500 µl of 1X PBS to the first and last row of a 24-well plate for humidification in order to help minimize medium evaporation. Seed the cells into ultra-low attachment cells plates at a density of 2,000 cells per well in 1 ml of tumor sphere medium (2,000 cells/ml).
NOTE: The number of cells used for tumor sphere formation assays may vary between tumor types. - Treat at least 4 wells with vehicle (negative control) and 4 wells with each allocated treatment, e.g., 3 mM of metformin. Place the cells in an incubator set to 37 °C and supply the cells with 5% CO2 for one week.
NOTE: The medium should not be changed in order to allow the undisturbed formation of tumor spheres, but can be topped up with growth factors on a daily basis as they are not stable in culture medium. - Every other day add treatment, e.g., 3 mM of metformin or vehicle to each of the wells. Assess the number of formed tumor spheres after 5 and/or 7 days by the use of an automated cell counter that allows for counting of larger structures (Figure 1).
NOTE: Only tumor spheres with at least 40 µm should be considered and can be categorized as small (40 - 80 µm) or large (80 - 120 µm), respectively. The results can be illustrated as the percentage of tumor spheres divided by the initial number of cells seeded (e.g., 2,000 cells).
- Serial Passaging of First Generation Tumor Spheres
- After 7 days of incubation harvest the tumor spheres using a 40 µm cell strainer and centrifuge them for 5 min at 900 x g at RT.
- Dissociate the pellet of tumor spheres to single cells using trypsin, and then expand the obtained single cell cells suspension again for another 7 days.
Subscription Required. Please recommend JoVE to your librarian.
Representative Results
Figure 1. Metformin Treatment Inhibits Oxygen Consumption and Induces ROS Production. (A) Metformin addition inhibits oxygen consumption (OCR) of sphere-derived cells. Two different PDAC secondary spheres were treated with metformin and OCR changes were measured by extracellular flux analysis. Rotenone injection was used as a control for total mitochondrial OCR consumption. X-axis represents the oxygen consumption rate in pmol of oxygen/hr normalized by the protein content in each well. (B) PDAC spheres used in A were treated for 8 hr with metformin and ROS production was assessed by flow cytometry using carboxy-DCFDA. Left, representative flow cytometry plots. Right, summary of data from three independent experiments. Please click here to view a larger version of this figure.
Subscription Required. Please recommend JoVE to your librarian.
Materials
Name | Company | Catalog Number | Comments |
24-well Ultra-low Attachment Plates | Corning | 3474 | |
Sterile 1x Dulbecco’s Phosphate Buffered Saline | Sigma | D8537 | |
Metformin | Sigma | D150959-5G | |
Trypsin solution, 0.05% | Life technologies | 25300054 | |
Incubator with CO2 input | |||
CASY Cell Counter and Analyzer for proliferation and viability measurement | Roche Innovatis | AG CASY Model TTC 45,60,150 μm | |
Counting Chamber/ Hemocytometer | Hausser Scientific Co | 3200 | |
50 ml centrifuge tubes | Corning | 430828 | |
15-ml polypropylene conical tube | BD Falcon | 352097 | |
50-ml polypropylene conical tube | BD Falcon | 352070 |